Dirk Witters
Director/Board Member at IMMUNOPRECISE ANTIBODIES LTD.
Net worth: 2 328 $ as of 30/04/2024
Profile
Dirk Witters has held director positions at ImmunoPrecise Antibodies Ltd.
and BioStrand BV.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/01/2024 | 1,950 ( 0.01% ) | 2 328 $ | 30/04/2024 |
Dirk Witters active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Director/Board Member | 05/09/2023 |
BioStrand BV
 BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The private company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
| Private companies | 1 |
|---|---|
BioStrand BV
BioStrand BV Miscellaneous Commercial ServicesCommercial Services Part of ImmunoPrecise Antibodies Ltd., BioStrand BV is a Belgian company that offers an AI-powered biotherapeutic SaaS platform to accelerate drug discovery. The private company is based in Diepenbeek, Belgium. BioStrand's LensAI provides data solutions for simplified management, insights, integration, and collaboration. The platform helps researchers discover drug discovery insights faster and master big omics data challenges with multi-dimensional integration. The company was founded in 2019 by Dirk Van Hyfte and Ingrid Brands, with Ingrid Brands serving as the CEO since then. BioStrand was acquired by ImmunoPrecise Netherlands BV on April 14, 2022 for $35.10 million. | Commercial Services |
- Stock Market
- Insiders
- Dirk Witters
